44 patients with high-risk (n = 39) or intermediate-risk (n = 5) neuroblastoma were treated with protons. With a median follow-up of 27.6 months, eight patients...

386 children with nonmetastatic grade II/III intracranial ependymoma received proton therapy. With the median follow-up of 5 years, the 7-year local control...

77 patients (38 proton and 39 photon) were evaluated with a median follow-up time of 2.2 years. This study reported no significant differences in symptomatic...

Twenty adults with medulloblastoma (≥ 22 years old) received postoperative proton CSI. This study reported no acute ≥ grade 3 gastrointestinal or hematologic...

Sixty-seven patients with unresected spinal chordomas treated with PBT were evaluated. With a median follow-up of 56.2 months, 5- and 8-year OS were 83.5 % and...

This study reported clinical outcomes of 68 patients with major salivary gland tumors including the parotid gland (75.0%) and adenoid cystic carcinoma (22.1%)...

Seventy-seven patients with nonmetastatic NPC received IMPT (n=28) or IMRT(n=49). With a median follow-up time of 30.3 months, IMPT was associated with lower...

Among the 292 patients with nonmetastatic oropharyngeal cancer of which 272 [93%] were HPV–positive tumors, 58 patients (20%) were treated with IMPT and 234 (80...

For the 26 patients with salivary gland tumor treated with PBSPT, at a median follow-up time of 46 months, 5 (19%), 2 (8%), 3 (12%) and 2 (8%) patients...

With data of 41 patients with stage III NSCLC who received PBT of 74 GyE with concurrent chemotherapy, this study reported that bone V5-20 and lung V5-50 were...